Delving into the Latest Updates on Huons Biopharma Co. Ltd. with Synapse

A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of HU-045 Compared to Xeomin® in Adult Patients With Moderate or Severe Glabellar Lines

A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase II Clinical Trial to Evaluate the Efficacy and Safety of HU-045 and Xeomin® in Patients With Moderate to Severe Glabellar Lines

开始日期2024-06-20

申办/合作机构

Huons Biopharma Co. Ltd.

NCT05964257

/ Active, not recruiting临床3期

A Double-blind, Randomized, Placebo-controlled, Multi-center, Phase III Study to Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric Hypertrophy.

A double-blind, randomized, placebo-controlled, multi-center, phase III study to evaluate the efficacy and safety of LIZTOX in subjects with benign Masseteric hypertrophy

开始日期2023-07-25

申办/合作机构

Huons Biopharma Co. Ltd.

100 项与 Huons Biopharma Co. Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Huons Biopharma Co. Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 Huons Biopharma Co. Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Huons Biopharma Co. Ltd. 相关的转化医学

登录后查看更多信息